Oncodermatology
162,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
81 °P sammeln
  • Gebundenes Buch

The purpose of this book is to outline the topics that are critical in the dermatological approach to patients with cancer. This purpose will be accomplished by discussing the value of a multidisciplinary approach, and case examples will be used, including some from the Hospital Sírio-Libanês, a pioneering institution in the treatment of cancer. In all, the book will present and discuss the best global evidence for the dermatologic care of patients with cancer, skin cancer, and solid organ- and bone-marrow-transplanted patients. The clinical, surgical, pathologic, imaging, radiotherapy,…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The purpose of this book is to outline the topics that are critical in the dermatological approach to patients with cancer. This purpose will be accomplished by discussing the value of a multidisciplinary approach, and case examples will be used, including some from the Hospital Sírio-Libanês, a pioneering institution in the treatment of cancer. In all, the book will present and discuss the best global evidence for the dermatologic care of patients with cancer, skin cancer, and solid organ- and bone-marrow-transplanted patients.
The clinical, surgical, pathologic, imaging, radiotherapy, oncology and palliative care aspects of the dermatologic care of cancer patients will be covered. The book will also discuss subjects such as genetics, biology, evidence-based medicine, and new diagnostic methods and tools such as dermoscopy and confocal microscopy.

Chapters will be based on the following key areas: educating clinicians on how to prevent skin cancer in patients, screening and counseling, diagnosis and treatment of pigmented lesions, melanoma and nonmelanoma skin cancer, cutaneous lymphomas, sarcomas, leukemic and lymphomatous infiltrations, cutaneous metastases, cutaneous paraneoplasic manifestations and cutaneous adverse reactions to chemotherapy and radiation treatment.
The primary audiences are dermatologists, oncologists, radioncologists and oncologic surgeons. The secondary audience is residents in these fields. The goal is to prepare and update all specialists on this important clinical and research area.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Cristina M. Z. Abdalla, MD, PhD Hospital Sírio-Libanês São Paulo, Brazil Coordinator of the oncodermatology post-graduation program of Hospital Sírio-Libanês Master's in Dermatology and PhD in Health Science at FMUSP (Faculdade de Medicina da Universidade de São Paulo, Brazil), member of the Brazilian Society of Dermatology, the Brazilian Society of Dermatological Surgery, the Brazilian Melanoma Group, the American Academy of Dermatology, and the International Society of Dermatoscopy. International Dermoscopy Diploma-  University of Graz. Practice in oncodermatology, clinical dermatology (inpatient and outpatient clinic), dermoscopy, confocal microscopy, skin cancer surgery and management of side effects affecting the skin, hair, and nails of cancer patients.   José Antonio Sanches, MD, PhD Hospital Sírio-Libanês São Paulo, Brazil, Hospital das Clínicas of the University of São Paulo Medical School,Brazil. Residency in Radiation Oncology, Hospital A.C. Camargo Cancer Center; Residency in Dermatology, Hospital das Clínicas, University of São Paulo Medical School. Master and PhD degree in Health Science at the University of São Paulo. Full Professor and Chair of the Department of Dermatology at the University of São Paulo. Member of the skin cancer group of Hospital Sírio-Libanês, coordinator of the oncodermatology post-graduation program of Hospital Sírio-Libanês. Supervisor of the Outpatient Clinic of the Cutaneous Oncology Unit of the Dermatological Clinic Division of the Hospital das Clínicas of the University of São Paulo Medical School (cutaneous lymphomas and correlated diseases, nonmelanoma cutaneous cancer and melanoma). in Masters and PhD researcher in Health Science at the University of São Paulo Medical School. Member of the Brazilian Melanoma Group, the American Academy of Dermatology, and the International Society for CutaneousLymphoma. Member and ex-president of the Brazilian Society of Dermatology. Research in cutaneous oncology: cutaneous lymphomas; melanoma and non-melanoma skin cancers.   Rodrigo Ramella Munhoz, MD Full attending - Hospital Sírio-Libanês São Paulo, Brazil Program Director - Medical Oncology Fellowship Program - Hospital Sírio Libanês Coordinator -  Oncodermatology post graduation program - Hospital Sírio-Libanês Graduated from Universidade Estadual de Campinas - UNICAMP (Brazil); Residency in Internal Medicine - Universidade Estadual de Campinas - UNICAMP (Brazil); Fellowship in Clinical Oncology Hospital Sírio Libanês, Advanced Clinical Fellowship in Melanoma / Sarcomas- Memorial Sloan Kettering Cancer Center; Member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) and Sociedade Brasileira de Oncologia Clínica (SBOC). Vice-President- Grupo Brasileiro de Melanoma. Founding-President - Grupo Brasileiro de Sarcomas.     Francisco Aparecido Belfort, MD Surgical Oncologist of Sirio Libanês Hospital, Oswaldo Cruz Hospital and and BP Mirante Hospital. Graduated in Medicine at PUCSP - Faculty of Medicine of Sorocaba. Residency in Radiotherapy at Fundação Antonio Prudente - Hospital AC Camargo and Residency in Oncology Surgery - Fundação Antonio Prudente - Hospital AC Camargo Former Physician of the Department of Skin Tumors at Hospital AC Camargo, Fundação Antonio Prudente PhD in Medicine from the Federal University of São Paulo (UNIFESP) Coordinator of Module XIII - Surgical treatment of advanced tumors - Specialization Course in Dermatology Oncology Member of the Brazilian Melanoma Group, the Brazilian College of Surgeons, the Brazilian Society of Surgical Oncologist, the Brazilian Society of Dermatological Surgery, the Brazilian Society of ClinicalOncology. Member of the Society of Surgical Oncology (SSO), the International Sentinel Node Society (ISNS), and the Australia and New Zealand Melanoma Trials Group (ANZMTG).